Berra Yazar-Klosinski: MDMA ("Ecstasy"), PTSD, Psychotherapy & MAPS | #26

Mind & Matter

English - June 11, 2021 04:00 - 1 hour - 75.2 MB - ★★★★★ - 15 ratings
Science Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Chris Timmermann: Dimethyltryptamine (DMT), Brain Waves & the Psychedelic Experience | #25

Next Episode: Genomics, CRISPR, Synthetic Biology, Biotechnology Startups, & Succeeding With Disabilities | George Church | #27

Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.

SUPPORT
Support the show on Patreon
Organize your digital highlights & notes w/ Readwise (2 months free w/ subscription)
Start your own podcast (get $20 Amazon gift card after signup)
Buy Mind & Matter t-shirts
Connect with Nick Jikomes on Twitter
Download the podcast & follow Nick at his website

SPONSORS
Learn more about our podcast sponsor, Dosist

ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.

Support the show (https://www.patreon.com/nickjikomes)

Twitter Mentions

@trikomes